Open AccessOnasemnogene abeparvovec for spinal muscular atrophy: The costlier drug ever
Author(s) -
R. C. Mahajan
Publication year - 2019
Publication title -
international journal of applied and basic medical research/international journal of applied and basic medical research
Language(s) - English
Resource type - Journals
eISSN - 2248-9606
pISSN - 2229-516X
DOI - 10.4103/ijabmr.ijabmr_190_19
Subject(s) - smn1 , spinal muscular atrophy , sma* , medicine , motor neuron , weakness , muscle atrophy , atrophy , drug , physical medicine and rehabilitation , disease , surgery , pharmacology , mathematics , combinatorics